"Residency Five" guarantees each playwright three world-premiere productions of new plays over the course of a five-year residency; specific productions will be announced at a later time. Each playwright will receive a significant cash award, full health benefits, a stipend to attend theater, and access to Signature's resources and staff.
As previously announced, Signature will launch its new home with Athol Fugard as its inaugural "Residency One" playwright, and the company will also expand its "Legacy Program," by presenting work of past playwrights-in-residence.
For more information, visit /www.signaturetheatre.org.
Share via Email
Don't show this again.